# AMG 761 in Adults With Asthma

> **NCT01514981** · PHASE1 · TERMINATED · sponsor: **Amgen** · enrollment: 7 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AMG 761
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01514981
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Administrative decision
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514981, "AMG 761 in Adults With Asthma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01514981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*